Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Allocated but not treated: the silent 16% - Authors' reply.

Other

Horby P. et al, (2022), Lancet, 399, 1775 - 1776

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

Journal article

HERRINGTON W., (2022), Nephrology, Dialysis and Transplantation

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Journal article

Horby PW. et al, (2021), Lancet Respiratory Medicine, 9, 1419 - 1426

Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.

Working paper

Horby P. et al, (2021), Lancet, 398

Making trials part of good clinical care: lessons from the RECOVERY trial

Journal article

Pessoa-Amorim G. et al, (2021), Future Healthcare Journal, 8, e243 - e250

Load More